{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T19:13:26Z","timestamp":1790363606550,"version":"4.1.0"},"reference-count":26,"publisher":"The Journal of Rheumatology","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2010,11]]},"abstract":"<jats:sec><jats:title>Objective.<\/jats:title><jats:p>Since Wegener\u2019s granulomatosis (WG) represents a relapsing disease, efforts have been made to reliably predict relapses using blood tests. Followup measures such as conventionally determined C-reactive protein (CRP), antineutrophil cytoplasmic antibody (C-ANCA) titer, and proteinase-3 (PR3) ELISA are applied. We evaluated whether during remission elevated highly sensitive CRP (hsCRP) precedes relapse as a marker of subclinical inflammation and thus might improve clinical assessment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods.<\/jats:title><jats:p>We investigated 227 sera of 57 patients with WG: 74 sera collected from patients in remission who subsequently relapsed (before relapse), 30 sera collected during relapse, and 123 sera from patients in remission without relapse. We also distinguished between major and minor relapse. hsCRP, conventionally determined CRP (CRP), C-ANCA, PR3-ELISA, and erythrocyte sedimentation rate (ESR) were measured using commercial kits, and levels were correlated to clinical status.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results.<\/jats:title><jats:p>Only hsCRP and ANCA titer, but not CRP levels, were higher in sera from patients who subsequently relapsed versus those who did not, indicating patients at risk. Levels of hsCRP, CRP, and ESR were higher in sera collected during relapse than in the sera before relapse. hsCRP, conventional CRP, and ESR were also higher in samples collected during major relapse than before major relapse. Looking at the levels just before relapse compared to previous levels during remission, none of these measures rose directly before the clinical manifestation of the relapse.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion.<\/jats:title><jats:p>Our study provides evidence for an additional value of hsCRP in the clinical assessment of patients with WG.<\/jats:p><\/jats:sec>","DOI":"10.3899\/jrheum.100302","type":"journal-article","created":{"date-parts":[[2010,8,18]],"date-time":"2010-08-18T02:07:47Z","timestamp":1282097267000},"page":"2319-2325","source":"Crossref","is-referenced-by-count":42,"title":["Use of Highly Sensitive C-Reactive Protein for Followup of Wegener\u2019s Granulomatosis"],"prefix":"10.3899","volume":"37","author":[{"given":"ANNA-ISABELLE","family":"K\u00c4LSCH","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ELENA","family":"CSERNOK","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DOMINIK","family":"M\u00dcNCH","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RAINER","family":"BIRCK","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BENITO A.","family":"YARD","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WOLFGANG","family":"GROSS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"THORSTEN","family":"K\u00c4LSCH","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WILHELM H.","family":"SCHMITT","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2262","published-online":{"date-parts":[[2010,8,17]]},"reference":[{"key":"2018112909250898000_37.11.2319.1","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(85)91147-X","article-title":"Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener\u2019s granulomatosis","volume":"1","author":"van der Woude","year":"1985","journal-title":"Lancet"},{"key":"2018112909250898000_37.11.2319.2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2005.09.022"},{"key":"2018112909250898000_37.11.2319.3","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-147-9-200711060-00005"},{"key":"2018112909250898000_37.11.2319.4","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/16.8.1631"},{"key":"2018112909250898000_37.11.2319.5","doi-asserted-by":"publisher","DOI":"10.1016\/S0162-3109(99)00007-7"},{"key":"2018112909250898000_37.11.2319.6","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1080\/10408360290795556","article-title":"High sensitivity C-reactive protein: an emerging role in cardiovascular risk assessment","volume":"39","author":"Benzaquen","year":"2002","journal-title":"Crit Rev Clin Lab Sci"},{"key":"2018112909250898000_37.11.2319.7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199901143400207"},{"key":"2018112909250898000_37.11.2319.8","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.19.2481"},{"key":"2018112909250898000_37.11.2319.9","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780200505"},{"key":"2018112909250898000_37.11.2319.10","first-page":"993","article-title":"Biological markers in inflammatory rheumatic diseases","volume":"41","author":"Hilliquin","year":"1995","journal-title":"Cell Mol Biol"},{"key":"2018112909250898000_37.11.2319.11","first-page":"2488","article-title":"Current status of outcome measures in vasculitis: focus on Wegener\u2019s granulomatosis and microscopic polyangiitis. Report from OMERACT 7","volume":"32","author":"Merkel","year":"2005","journal-title":"J Rheumatol"},{"key":"2018112909250898000_37.11.2319.12","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/978-1-4757-9182-2_55","article-title":"Alpha-1-antitrypsin, CRP and interleukin-6 in ANCA-positive vasculitis","volume":"336","author":"Gronhagen-Riska","year":"1993","journal-title":"Adv Exp Med Biol"},{"key":"2018112909250898000_37.11.2319.13","first-page":"341","article-title":"Objective monitoring of activity in Wegener\u2019s granulomatosis by measurement of serum C-reactive protein concentration","volume":"21","author":"Hind","year":"1984","journal-title":"Clin Nephrol"},{"key":"2018112909250898000_37.11.2319.14","first-page":"127","article-title":"ANCA and predicting relapse in systemic vasculitis","volume":"88","author":"Jayne","year":"1995","journal-title":"QJM"},{"key":"2018112909250898000_37.11.2319.15","doi-asserted-by":"publisher","DOI":"10.1053\/sarh.2000.8366"},{"key":"2018112909250898000_37.11.2319.16","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.14.85"},{"key":"2018112909250898000_37.11.2319.17","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/09674845.2009.11730261","article-title":"Evaluation of some markers of subclinical atherosclerosis in Egyptian young adult males with abdominal obesity","volume":"66","author":"Abdou","year":"2009","journal-title":"Br J Biomed Sci"},{"key":"2018112909250898000_37.11.2319.18","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.17.10.2167"},{"key":"2018112909250898000_37.11.2319.19","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/clinchem\/43.1.52","article-title":"Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications","volume":"43","author":"Macy","year":"1997","journal-title":"Clin Chem"},{"key":"2018112909250898000_37.11.2319.20","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1161\/01.ATV.16.9.1156","article-title":"Interindividual and intraindividual variability in plasma fibrinogen, TPA antigen, PAI activity, and CRP in healthy, young volunteers and patients with angina pectoris","volume":"16","author":"de Maat","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2018112909250898000_37.11.2319.21","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/art.1780360312","article-title":"Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with Wegener\u2019s granulomatosis","volume":"36","author":"Kerr","year":"1993","journal-title":"Arthritis Rheum"},{"key":"2018112909250898000_37.11.2319.22","first-page":"241","article-title":"Serial ANCA testing is useful in monitoring disease activity of patients with ANCA-associated vasculitides","volume":"13","author":"Tervaert","year":"1996","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2018112909250898000_37.11.2319.23","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200009)43:9<2025::AID-ANR13>3.0.CO;2-O"},{"key":"2018112909250898000_37.11.2319.24","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1381.002"},{"key":"2018112909250898000_37.11.2319.25","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2002.01978.x"},{"key":"2018112909250898000_37.11.2319.26","doi-asserted-by":"publisher","DOI":"10.1002\/art.11025"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.100302","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T16:41:29Z","timestamp":1591807289000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.100302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,17]]},"references-count":26,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2010,11,1]]},"published-print":{"date-parts":[[2010,11]]}},"alternative-id":["10.3899\/jrheum.100302"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.100302","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,17]]}}}